Pangen Biotech (XKRX:222110) Ending Cash Position : ₩1,430 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Pangen Biotech Ending Cash Position?

Pangen Biotech's Ending Cash Position for the quarter that ended in Dec. 2024 was ₩1,430 Mil.

Pangen Biotech's quarterly Ending Cash Position increased from Jun. 2024 (₩1,245 Mil) to Sep. 2024 (₩2,135 Mil) but then declined from Sep. 2024 (₩2,135 Mil) to Dec. 2024 (₩1,430 Mil).

Pangen Biotech's annual Ending Cash Position declined from Dec. 2022 (₩892 Mil) to Dec. 2023 (₩45 Mil) but then increased from Dec. 2023 (₩45 Mil) to Dec. 2024 (₩1,430 Mil).

Pangen Biotech Ending Cash Position Historical Data

The historical data trend for Pangen Biotech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pangen Biotech Ending Cash Position Chart

Pangen Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

8,139.30

8,901.48

892.46

45.40

1,430.11

Pangen Biotech Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															45.40	4,336.28	1,244.96	2,134.61	1,430.11

Pangen Biotech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Pangen Biotech's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	45.405	+	1384.709
	=	1,430

Pangen Biotech's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2159.427	+	-729.313
	=	1,430

Pangen Biotech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Pangen Biotech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Pangen Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pangen Biotech Inc (XKRX:222110) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

4Floor Innoplex 2-dong, 306 Sinwon-ro, Yeongtong-gu, Gyeonggi-do, Suwon-si, KOR, 16675

Website

http://www.pangen.com

Pangen Biotech Inc is a biotechnology company. It is engaged in development of biosimilar products and technology transfer services for biologics development. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc.

Pangen Biotech Headlines

No Headlines